CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy and safety of tenofovir disoproxil fumarate (TDF) monotherapy in a European multicenter cohort of nucleos(t)ide experienced patients with chronic hepatitis B virus (HBV)-infection
DOI 10.1055/s-0030-1264032
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF van Bömmel, RA De Man, P Ferenci, JG Reijnders, JP Bronowicki, A Brodzinski, B Fülöp, H Wedemeyer, K Deterding, A Erhardt, D Hüppe, M Bourlière, C Sarrazin, J Trojan, P Buggisch, J Petersen, U Spengler, K Stein, A Pariente, M Schuchmann, HE Wasmuth, K Rutter, HH Feucht, M Joachim, T Berg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The nucleotide analogue tenofovir disoproxil fumarate (TDF) was shown to be an effective treatment for treatment-naïve patients up to three years of treatment (Marcellin & Heathcote et al, AASLD 2009). The aim of this multicenter cohort study is to study the long term outcome of TDF treatment in patients with previous failure to nucleos(t)ide analogues. Methods: Data from all HBV monoinfected patients treated…
Zitieren
Zitierempfehlung
F van Bömmel, RA De Man, P Ferenci, JG Reijnders, JP Bronowicki, A Brodzinski, B Fülöp, H Wedemeyer, K Deterding, A Erhardt, D Hüppe, M Bourlière, C Sarrazin, J Trojan, P Buggisch, J Petersen, U Spengler, K Stein, A Pariente, M Schuchmann, HE Wasmuth, K Rutte… (2010) Efficacy and safety of tenofovir disoproxil fumarate (TDF) monotherapy in a European multicenter cohort of nucleos(t)ide experienced patients with chronic hepatitis B virus (HBV)-infection. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0030-1264032
Mit CareLit weiterarbeiten